Ohio State has more than 200 active research trials for heart and vascular diseases.
The Ohio State University's Dorothy M. Davis Heart and Lung Research Institute (DHLRI) is one of the nation’s few free-standing facilities devoted entirely to the research of diseases affecting the heart, lungs and blood vessels.
Researchers at the DHLRI work closely with clinicians at Ohio State's Ross Heart Hospital to translate their findings into new procedures and medical therapies for patients with heart and vascular disease in the areas of:
- Cardiac surgery
- Electrophysiology
- Heart failure
- Sleep disorders associated with heart disease
- Interventional cardiology
- Vascular surgery
- Prevention
- Stem cell research
- Noninvasive cardiac imaging
- Duchenne muscular dystrophy
For information about enrolling in clinical trials at Ohio State’s Ross Heart Hospital, contact the Heart and Vascular Research Unit (HVRO) at 614-688-5901 or cardiovascular.research@osumc.edu. You can also review current research studies at Ohio State and register to become a participant at our Participate in Research Studies page.
Heart and Vascular Research at Ohio State
Research Shows Promise for Duchenne Muscular Dystrophy
Ohio State's heart and vascular experts are hoping to extend the lives of those living with this rare and deadly disease.
Pacemaker Implanted Directly in Heart
Ohio State was one of the first in the country to implant a tiny, high-tech pacemaker, only 24 millimeters long, directly into the heart of patients, without surgery.
Ohio State Advances Heart Failure Care
Ohio State led the national study of a new heart failure monitoring device and was the first in the nation to use the device in patients after it received FDA approval.
Heart Attack Recovery Research
An Ohio State team is researching how adult stem cells can help the heart recover more quickly after a heart attack.
Our Leaders
Our leaders
Peter Mohler, PhD
Director, Davis Heart and Lung Research Institute
Dr. Mohler, a prominent medical researcher, earned a doctorate in molecular physiology in 2000 at the University of North Carolina at Chapel Hill and completed a post-doctoral fellowship in 2004 at the Howard Hughes Medical Institute at Duke University. He was named a Pew Scholar by the Pew Charitable Trusts in 2007 and a Kavli Scholar of the U.S. National Academy of Sciences in 2009. His research program focuses on solving the pathways underlying such conditions as cardiac arrhythmia, diabetes and neurological dysfunction.
William Abraham, MD, FACP, FACC
Director, Division of Cardiovascular Medicine and Deputy Director, Ohio State’s Davis Heart and Lung Research Institute
Dr. Abraham is routinely recognized as one of the “Best Doctors in America” and was the inaugural designated Chair of Excellence in Cardiovascular Medicine at Ohio State’s College of Medicine. He has co-edited a leading textbook on heart failure, has been a principal investigator in more than 100 multicenter clinical drug and device trials and has authored more than 600 professional works. Dr. Abraham earned his medical degree from Harvard Medical School and completed his residency in internal medicine and fellowships in cardiology and heart failure/cardiac transplantation at the University of Colorado.